Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

1

Ali Fattaey appointed Chief Executive Officer of MetaboMed

September 9, 2020 Research and Development

MetaboMed has appointed Ali Fattaey, Ph.D. as its new Chief Executive Officer.Fattaey has over 20 years experience in the industry. …
Appointment
alexion_sign

Alexion’s Ondexxya approved for NHS Scotland to treat uncontrolled and life-threatening bleeds

September 9, 2020 Research and Development, Sales and Marketing Alexion, NHS, Ondexxya, Scotland, nhs scotland

The Scottish Medicines Consortium (SMC) has given its recommendation to Alexion’s Ondexxya (andexanet alfa) to routine use on NHS Scotland …
News

AstraZeneca slams brakes on COVID-19 vaccine trial over unexplained participant illness

September 9, 2020 Research and Development AstraZeneca, COVID-19, pharma

Global trials for AstraZeneca’s much-hyped COVID-19 vaccine, currently in development in partnership with the University of Oxford, have been halted …
News
800px-informal_meeting_of_ministers_for_foreign_affairs_gymnich

Gatherings of over six people to be banned in England from Monday

September 9, 2020 Research and Development Lockdown, coronavirus

England is set to increase lockdown restrictions across the country after a surge in coronavirus cases.  Currently, most outdoor gatherings …
News
download_1

Roche to start new trials of Ocrevus to defend multiple sclerosis franchise

September 9, 2020 Research and Development MS, MS drug, Roche

Roche is to begin expanding trials of Ocrevus in multiple sclerosis (MS) patients to defend its MS franchise from its …
News
china_v_0_1

Major vaccine manufacturers sign COVID-19 safety pledge

September 9, 2020 Research and Development CDC, FDA, anti vaxx, anti-vaxx, coronavirus vaccine

Nine vaccine manufactures have signed a pledge to uphold ethical standards while producing their treatments for COVID-19.  The companies involved …
News
carter_percy

FibroGen names appointment for newly created Chief Scientific Officer role

September 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, fibrogen

FibroGen has created the new role of Chief Scientific Officer and appointed Dr Percy Carter to the position, it has …
Appointment
molly_henderson

Advaxis Chief Financial Officer resigns

September 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Advaxis

Molly Henderson, the Chief Financial Officer and Executive Vice President of Advaxis, has announced her resignation that will take effect …
Appointment
sanofi_hq__boetie_hall_web

Extension study reveals Dupixent’s benefit can last up to three years in moderate-to-severe asthma

September 8, 2020 Manufacturing and Production, Research and Development Dupixent, Sanofi, asthma, pharma

New findings have been revealed from an extension study of Sanofi’s interleukin-4 (IL-4) and interleukin-13 (IL-13) inhibitor Dupixent (dupilumab) in …
News
shutterstock_95714119

Meta-analysis reinforces efficacy of commercially available steroids in hospitalised COVID-19 patients

September 4, 2020 Medical Communications, Research and Development COVID-19, pharma, steroids

A new meta-analysis of seven studies worldwide investigating the benefit for commercially available steroid therapies in the treatment of COVID-19 …
News
shutterstock_159488225

Akebia Therapeutics’ HIF-PH inhibitor passes efficacy goals in chronic kidney disease without dialysis, but falls short on safety

September 4, 2020 Medical Communications, Research and Development Akebia Therapeutics, kidney disease, pharma, vadadustat

Akebia Therapeutics has pulled back the veil on data from the second of two Phase 3 clinical trials for its …
News
gustave_perna_29510410783

Four COVID-19 vaccine trials backed by Operation Warp Speed will likely fail, according to a new report

September 3, 2020 Research and Development

Four late-stage trials of vaccine candidates partly funded by the US Operation Warp Speed are likely to fail, according to …
News
shutterstock_138095450

Gilead and Jounce Therapeutics forge immuno-oncology partnership worth a potential $700m+

September 2, 2020 Research and Development, Sales and Marketing Gilead, jounce, oncology, pharma

Gilead and Jounce Therapeutics have come together in a new immuno-oncology partnership potentially worth over $700 million. The primary drive …
News
800px-president_trump_delivers_remarks_at_the_white_house_coronavirus_task_force_briefing_49716740721

US won’t join COVAX coronavirus vaccine initiative because it is linked to the WHO

September 2, 2020 Research and Development Trump, Trump Administration, US, USA

The US has said it will not participate in an international effort to develop and distribute a coronavirus vaccine.COVAX is …
News
type_2_diabetes_28081593711_1

Novo Nordisk launches new Rybelsus pill for type 2 diabetes in the UK

September 2, 2020 Research and Development Novo Nordisk, diabetes, type 2, type 2 diabetes

Novo Nordisk’s new type 2 diabetes treatment Rybelsus is now available for doctors and physicians in the UK to prescribe …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025